检索

标题
作者
Clinical features of chronic hepatitis B in the presence of metabolic syndrome and insulin resistance
Tkachenko L., Maleev V.
Endothelial dysfunction markers (VCAM-1, vWF) in chronic hepatitis C
Antonova T., Romanova M., Lymar' I.
Current possibilities for treatment for hepatitis C virus-induced cryoglobulinemic vasculitis and B-cell lymphoma
Ignatova T., Mukhin N.
HCV-ASSOCIATED CRYOGLOBULINEMIC VASCULITIS
Vasiliev V., Palshina S., Logvinenko O., Safonova T., Rodionova E., Varlamova E., Nekrasova T., Radenska-Lopovok S., Probatova N., Alexandrova E., Nasonov E.
Metabolic correctors based on siccine acid as pathogenic therapy in chronic virus hepatitis
Stel'makh V., Radchenko V., Kozlov V., Stelmakh V., Radchenko V., Kozlov V.
The parameters of collagen proteolytic and metabolic systems in chronic liver diseases of viral and toxic etiologies
Beloborodova E., Beloborodova E., Akbasheva O., Serebrov V., Chernogoryuk G., Rachkovskiy M., Purlik I., Ostanko V., Chvyrina D., Beloborodova E., Beloborodova E., Akbasheva O., Serebrov V., Chernogoryuk G., Rachkovsky M., Purlik I., Ostanko V., Chvyrina D.
Effects of interferon therapy onfunctional activity of platelets in chronic viral hepatitis andcirrhosis of the liver
Yagoda A., Koroi P.
Autoimmune manifestations in acute viralhepatitides
Volchkova Y., Allenov M., Umbetova К., Ivanovo I., Pak S.
Diagnostic accuracy of predictive indexes of liver fibrosis in patients with chronic hepatitis C
Maev I., Kuznetsova E., Andreev D., Dicheva D.
CLINICOMORPHOLOGICAL CHANGES OF THE LIVER IN ATHEROGENIC DYSLIPIDEMIAAND IN THE TREATMENT WITH STATINS
Lazebnik L., Zvenigorodskaya L., Morozov I., Shepeleva S.
Evaluation of lipid peroxidation processes in patients with chronic parenteral viral hepatitis and HIV co-infection depending on degree of inflammatory process activity in the liver
Kolesnikova L., Darenskaya M., Kolesnikov S., Grebenkina L., Rashidova M., Timofeeva E., Leshenko O., Nikitina O.
Hepatitis C virus-associated cryoglobulinemic vasculitis: A 20-year experience with treatment
Ignatova T., Kozlovskaya L., Gordovskaya N., Chernova O., Milovanova S., Novikov P., Nekrasova T., Beketova T., Mukhin N.
Myocardial injury associated with chronic hepatitis C: Clinical types and pathogenetic components
Strizhakov L., Karpov S., Fomin V., Lopatkina T., Tanashchuk E., Taranova M.
Use of a regional registry of chronic hepatitis patients to optimize antiviral therapy
Tkachenko L., Maleev V., Sannikova I., Titorenko M.
Alcoholic liver disease: State-of-the-art
Maev I., Abdurakhmanov D., Andreev D., Dicheva D.
The burden of viral hepatitides in the Russian Federation and ways of its reduction for the long term (in case of hepatitis C)
Iushchuk N., Znoĭko O., Iakushechkina N., Zyrianov S., Shut'ko S., Belyĭ P., Kozina A., Chapurin S., Churilin I., Lugovskikh E.
Telaprevir: New possibilities for antiviral treatment in patients with chronic hepatitis C
Nikitin I., Gogova L., Baĭkova I., Kisliakov V., Volynkina V.
Specific damage to the kidneys in patients with chronic hepatitis C associated with cryoglobulinemia
Milovanova S., Tegay S., Russkikh A., Kozlovskaya L., Milovanova S., Tegai S., Russkikh A., Kozlovskaya L.
An IL-6 level in the serum and urine in estimation of cryoglobulinemic vasculitis activity in patients with chronic hepatitis C associated with renal damage
Korotchaeva Y., Kozlovskaya L., Gordovskaya N., Speranskiy A., Korotchaeva Y., Kozlovskaya L., Gordovskaya N., Speransky A.
Characteristics of the cytokine profile and peripheral blood lymphocyte subpopulations in patients with chronic viral hepatitis B and C in respect to severity of morphological changes of the liver
Lazareva A., Volchkova E., Umbetova K., Chulanov V., Parkhomenko Y., Kiselevskiy M., Pak S., Lazareva A., Volchkova E., Umbetova K., Chulanov V., Parkhomenko Y., Kiselevsky M., Pak S.
HBeAg-negative chronic hepatitis
Ibragimova M., Krel P., Abdurakhmanov D.
Some aspects of laboratory diagnosis of viral hepatitis В and С
Iliyina E., Govorun V., Ivanikov I.
Diabetes mellitus and chronic liver diseases. Literature review (part 2): treatment features
Kalmykova Z., Kononenko I., Mayorov A.
Autoimmune liver disease (primary biliary cholangitis/autoimmune hepatitis-overlap) associated with sarcoidosis (clinical cases and literature review)
Burnevich E., Popova E., Ponomarev A., Nekrasova T., Lebedeva M., Filatova A., Shchanitcyna E., Ponomareva L., Beketov V., Bondarenko I., Tanashchuk E., Nikulkina E., Moiseev S.
Superinfection of hepatitis E as a factor in the development of acute hepatic encephalopathy on the background of HBV-cirrhosis of the liver
Baramzina S., Lyubeznova O., Bondarenko A., Protasov A.
Analysis of inpatient care for HIV-positive patients with malignant lymphomas and hepatitis over 5 years (2011—2015) at the A.S.Loginov Moscow Clinical Research Center, Moscow Healthcare Department
Pivnik A., Tumanova M., Chistyakova A., Dudina G., Dubnitskaya M., Mukhin O., Sergeeva E.
Possibilities of using cepeginterferon alpha-2b in double (cepeginterferon alfa-2b and ribavirin) and triple (simeprevir, cepeginterferon alpha-2b, and ribavirin) antiviral therapy regimens for chronic hepatitis C. A review of clinical trials and experience of everyday clinical practice
Znoyko O., Klimova E., Maevskaya M., Shuldyakov А., Linkova Y., Morozova M.
Analysis of ineffective antiviral therapy with pegylated interferon and ribavirin in a patient with chronic hepatitis C infected with HCV genotype 2
Znoyko O., Dudina K., Kozina A., Kalininа O., Yushchuk N.
Catalase gene rs1001179 polymorphism and oxidative stress in patients with chronic hepatitis C and ulcerative colitis
Bulatova I., Tret'iakova I., Shchekotov V., Shchekotova A., Ulitina P., Krivtsov A., Nenasheva O.
Endothelial dysfunction gene polymorphisms and the rate of liver fibrosis in chronic hepatitis C
Taratina O., Krasnova T., Samokhodskaia L., Lopatkina T., Tkachuk V., Mukhin N.
Antiviral therapy and risk for hepatocellular carcinoma in chronic viral hepatitis
Abdurakhmanov D.
A case of sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease) in a patient with diffuse large B-cell lymphoma and chronic hepatitis B virus infection
Melikian A., Kovrigina A., Giliazitdinova E., Gitis M.
Markers of intestinal infection agents in patients with acute viral hepatitis with cholestatic syndrome
Zuevskaya S., Belaya O., Volchkova E., Andrekayte N., Zuevskaya S., Belaya O., Volchkova E., Andrekaite N.
Comparative characteristics of porphirine metabolism in chronic viral diseases of the liver
Krivosheev A., Kondratova M., Krivosheev B., Morozov D., Danilenko D., Krivosheev A., Kondratova M., Krivosheev B., Morozov D., Danilenko D.
HCV genome variability in acute and chronic viral hepatitis C
Yushchuk N., Klimova E., Znoyko O., Gadzhikulieva M., Il'ina E., Yashina T., Malyshev N., Tsyganova E., Yuschuk N., Klimova E., Znoiko O., Gadzhikulieva M., Ilyina E., Yashina T., Malyshev N., Tsyganova E.
Comparative efficacy of combined treatment with intron A and pegintron in combination with ribavirin in patients with chronic hepatitis С
Gromova N., Bogomolov B.
Disorders of carbohydrate-lipid metabolism and galectin-3 level as factors of liver fibrosis progression in chronic hepatitis C
Kovalevа V., Zhevnerova N., Antonova T.
Treatment of chronic viral hepatitis C with direct acting antiviral agent: review
Malov V., Ubeeva E., Ubeeva I., Nikolaev S., Umbetova K.
Risk factors of unfavorable prognosis of chronic hepatitis C
Shchanitcyna S., Burnevich E., Nikulkina E., Filatova A., Moiseev S., Mukhin N.
The role of systemic inflammation in the pathogenesis of insulin resistance and metabolic syndrome in patients with chronic hepatitis C
Tkachenko L., Maleev V.
Diagnostic possibilities of methods for the evaluation of liver fibrosis in chronic viral hepatitis
Navrotsky A.
The efficiency and safety of anti-Helicobacter pylori therapy in patients with concomitant chronic hepatitis C
Andreev D., Maev I., Kucheryavyi Y., Dicheva D., Partsvania-vinogradova E.
Simeprevir in combination with pegylated interferon-α and ribavirin in the treatment of naïve patients with genotype 1 chronic hepatitis C
Burnevich É.
The therapeutic efficacy of cycloferon and the pharmacological activity of interferon inhibitors
Romantsov M., Ershov F., Kovalenko A., Belova O.
Long-term entecavir efficacy retention in the treatment of chronic hepatitis B with an outcome to hepatic cirrhosis caused by its resistant virus strain
Znoĭko O., Dudina K., Safiullina N., Karandashova I., Chulanov V.
Specific features of lymphoid infiltration in liver biopsy in patients with chronic viral hepatitis B and C
Umbetova K., Lazareva A., Kiselevskiy M., Parkhomenko Y., Volchkova E., Pak S., Umbetova K., Lazareva A., Kiselevsky M., Parkhomenko Y., Volchkova E., Pak S.
Regulators of fibrinolysis in chronic viral pathology of the liver
Yagoda A., Kopoy P., Yagoda A., Koroi P.
Characterization of cellular immunity parameters in children with acute viral hepatitis A
Budarina N., Belaya О., Chulanov V., Paimanov N., Pak S.
Hepatitis C virus - related cryoglobulinemic vasculitis with renal involvement current possibilities of diagnostic and treatment
Milovanova S., Kozlovskaya(Lysenko) L., Milovanova L., Gordovskaya N., Ignatova T., Taranova M., Androsova T.
Diabetes mellitus and chronic liver diseases. Part 1: general mechanisms of etiology and pathogenesis
Kalmykova Z., Kononenko I., Mayorov A.
51 - 100 的 133 信息 << < 1 2 3 > >> 

检索提示:

  • 检索的名词区分大小写
  • 常用字词将被忽略
  • 默认情况下只有在查询结果满足所有检索词才返回(例如,隐含AND)
  • 使用OR结合多个检索词,便于查找含有这些检索词的文章,例如education OR research
  • 使用括号来创建更复杂的查询; 例如:archive ((journal OR conference) NOT theses)
  • 使用引号检索一个完整的词组; 例如: "open access publishing"
  • 使用-或者NOT排除一个检索词; 例如:online -politics or online NOT politics
  • 在检索词里使用 *作为通配符匹配任何字符序列; 例如., soci* morality 将符合含有 "sociological" or "societal"的词语

##common.cookie##